What is Journey Medical Corporation's SG&A?

Journey Medical Corporation (DERM) reported SG&A of $10.11M in Q1 2026.

How has Journey Medical Corporation's SG&A changed year-over-year?

Journey Medical Corporation's SG&A decreased by 4.4% year-over-year, from $10.57M to $10.11M.

What is the long-term trend for Journey Medical Corporation's SG&A?

Over 4 years (2021 to 2025), Journey Medical Corporation's SG&A has grown at a 2.7% compound annual growth rate (CAGR), from $39.83M to $44.37M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Journey Medical Corporation DERM SG&A

SG&A at other companies

Bausch Health CompaniesBHC

$861M-0.7%

PTH

Pelthos Therapeutics Inc.PTHS

$21.1M+1,187%

Arcutis Biotherapeutics, Inc.ARQT

$74.08M+15.7%

HRO

HarrowHROW

$43.23M+6.7%

Catalyst PharmaceuticalCPRX

$49.32M+5.1%

Mirum Pharmaceuticals, Inc.MIRM

$96.33M+66.9%

Other financials

Income statement

See full

Revenue$16.0M+21.5%

Gross profit$9.7M+16.7%

Operating income-$1.5M+55.1%

Net income-$2.2M+45.2%

EPS (diluted)-$0.08+55.6%

Balance sheet

See full

Cash & equivalents$27.2M+29.2%

Total debt$25.5M+1.2%

Total equity$30.8M+43.1%

Total assets$91.5M+7.7%

Cash flow

See full

Operating cash flow$2.9M+203%

CapEx$3.8M—

Free cash flow-$6.0M—

Valuation

See full

Market cap$194.94M+20.9%

Enterprise value$193.19M+16.2%

P/S3×+0.2×

Profitability

See full

Gross margin65.4%-1.0pp

Operating margin-9.8%—

Net margin-14.8%—

FCF margin-43%—

Returns & leverage

See full

Return on equity-36.6%—

Debt / equity0.8×-0.3×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Journey Medical Corporation's SG&A?: Journey Medical Corporation (DERM) reported SG&A of $10.11M in Q1 2026.
How has Journey Medical Corporation's SG&A changed year-over-year?: Journey Medical Corporation's SG&A decreased by 4.4% year-over-year, from $10.57M to $10.11M.
What is the long-term trend for Journey Medical Corporation's SG&A?: Over 4 years (2021 to 2025), Journey Medical Corporation's SG&A has grown at a 2.7% compound annual growth rate (CAGR), from $39.83M to $44.37M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.